FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 314:208-212 January 23, 1986 Number 4 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

In a prospective, randomized trial, we compared intravenous acyclovir and vidarabine in the treatment of varicella-zoster virus infection in severely immunocompromised patients who presented within 72 hours of onset of the infection. Eleven patients were treated in each group. Cutaneous dissemination of infection occurred in none of the 10 acyclovir recipients and in 5 of the 10 vidarabine recipients who had presented with localized dermatomal disease (P = 0.016). As compared with vidarabine, acyclovir treatment shortened the median periods during which cultures were positive for the virus (four vs. seven days, P = 0.004) and new lesions formed (three vs. six days, P = 0.03). Acyclovir also shortened the median interval until the first decrease in pain (4 vs. 7 days, P = 0.005), the pustulation of all lesions (4 vs. 7 days, P = 0.0004), the crusting of all lesions (7 vs. 17 days, P = 0.0003), and the complete healing of lesions (17 vs. 28 days, P = 0.003). In addition, acyclovir reduced the incidence of fever (two vs. eight patients, P = 0.015). We conclude that acyclovir is better than vidarabine for the treatment of varicella-zoster infection in immunocompromised patients.

This article has been cited by other articles:

• Boeckh, M., Kim, H. W., Flowers, M. E. D., Meyers, J. D., Bowden, R. A. (2006). Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study. Blood 107: 1800-1805 [Abstract] [Full Text]  
• Acosta, E. P., Balfour, H. H. Jr. (2001). Acyclovir for Treatment of Postherpetic Neuralgia: Efficacy and Pharmacokinetics. Antimicrob. Agents Chemother. 45: 2771-2774 [Abstract] [Full Text]  
• (2000). Management of herpes virus infections following transplantation. J Antimicrob Chemother 45: 729-748 [Full Text]  
• Cohen, J. I., Brunell, P. A., Straus, S. E., Krause, P. R. (1999). Recent Advances in Varicella-Zoster Virus Infection. ANN INTERN MED 130: 922-932 [Abstract] [Full Text]  
• Eysenbach, G., Diepgen, T. L. (1998). Responses to Unsolicited Patient E-mail Requests for Medical Advice on the World Wide Web. JAMA 280: 1333-1335 [Abstract] [Full Text]  
• Shannon, K. M., Cowan, M. J., Matthay, K. K. (1987). Pediatric Bone Marrow Transplantation: Intensive Care Management. J Intensive Care Med 2: 328-344 [Abstract]  
• Hammond, E. (1987). Herpes-Zoster Infections in Children with Hodgkin's Disease. Journal of Pediatric Oncology Nursing 4: 23-29